Stay updated on Sacituzumab vs Chemo in HR+/HER2- Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab vs Chemo in HR+/HER2- Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab vs Chemo in HR+/HER2- Metastatic Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    NIH funding reference for 2018 was added to the funding information. A new publication citation by Sathe et al. on Sacituzumab Govitecan pharmacokinetics was added to the Publications/IPD section, and the revision tag was updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T20:10:41.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.5 replacing v3.6.4. This indicates a minor update to the page’s revision, likely affecting internal documents or UI rather than the study content.
    Difference
    0.0%
    Check dated 2026-08-08T10:38:39.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a new revision tag Revision: v3.6.4, replacing the previous v3.6.3. This indicates an internal version update that does not alter the study content or user-facing data.
    Difference
    0.0%
    Check dated 2026-07-25T05:38:13.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3, signaling a minor documentation update.
    Difference
    0.0%
    Check dated 2026-07-03T21:46:24.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page's revision line changed from Revision: v3.6.0 to Revision: v3.6.2. This update indicates a newer build of the Study Details page.
    Difference
    0.0%
    Check dated 2026-06-26T23:53:36.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    The page adds a recruitment status line 'No longer looking for participants' and introduces new help and join sections (How to Read a Study Record, Common Questions, How to Join a Study), with a formatting change from 'Intervention / Treatment' to 'Intervention/Treatment'. The study record version reference updated from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-12T14:25:38.000Z thumbnail image

Stay in the know with updates to Sacituzumab vs Chemo in HR+/HER2- Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab vs Chemo in HR+/HER2- Metastatic Breast Cancer Clinical Trial page.